| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-101 |
Sentence |
denotes |
CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. |
| T1 |
0-101 |
Sentence |
denotes |
CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. |
| T2 |
102-241 |
Sentence |
denotes |
Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. |
| T2 |
102-241 |
Sentence |
denotes |
Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. |
| T3 |
242-510 |
Sentence |
denotes |
Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimmerman, G. |
| T3 |
242-510 |
Sentence |
denotes |
Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimmerman, G. |
| T4 |
511-601 |
Sentence |
denotes |
A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K. |
| T4 |
511-601 |
Sentence |
denotes |
A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K. |
| T5 |
602-619 |
Sentence |
denotes |
R., Tortolani, A. |
| T5 |
602-619 |
Sentence |
denotes |
R., Tortolani, A. |
| T6 |
620-647 |
Sentence |
denotes |
J., Cerami, A. & Tracey, K. |
| T6 |
620-647 |
Sentence |
denotes |
J., Cerami, A. & Tracey, K. |
| T7 |
648-662 |
Sentence |
denotes |
J. (1995) Mol. |
| T7 |
648-662 |
Sentence |
denotes |
J. (1995) Mol. |
| T8 |
663-667 |
Sentence |
denotes |
Med. |
| T8 |
663-667 |
Sentence |
denotes |
Med. |
| T9 |
668-728 |
Sentence |
denotes |
1, 254-266, and Bianchi, M., Bloom, O., Raabe, T., Cohen, P. |
| T9 |
668-728 |
Sentence |
denotes |
1, 254-266, and Bianchi, M., Bloom, O., Raabe, T., Cohen, P. |
| T10 |
729-850 |
Sentence |
denotes |
S., Chesney, J., Sherry, B., Schmidtmayerova, H., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. & Tracey, J. (1996) J. |
| T10 |
729-850 |
Sentence |
denotes |
S., Chesney, J., Sherry, B., Schmidtmayerova, H., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. & Tracey, J. (1996) J. |
| T11 |
851-855 |
Sentence |
denotes |
Exp. |
| T11 |
851-855 |
Sentence |
denotes |
Exp. |
| T12 |
856-872 |
Sentence |
denotes |
Med., in press]. |
| T12 |
856-872 |
Sentence |
denotes |
Med., in press]. |
| T13 |
873-1039 |
Sentence |
denotes |
We have now elucidated the mechanism by which CNI-1493 inhibits macrophage TNF synthesis and show here that it acts through suppression of TNF translation efficiency. |
| T13 |
873-1039 |
Sentence |
denotes |
We have now elucidated the mechanism by which CNI-1493 inhibits macrophage TNF synthesis and show here that it acts through suppression of TNF translation efficiency. |
| T14 |
1040-1372 |
Sentence |
denotes |
CNI-1493 blocked neither the lipopolysaccharide (LPS)-induced increases in the expression of TNF mRNA nor the translocation of nuclear factor NF-kappa B to the nucleus in macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-kappa B-mediated transcriptional regulation of TNF. |
| T14 |
1040-1372 |
Sentence |
denotes |
CNI-1493 blocked neither the lipopolysaccharide (LPS)-induced increases in the expression of TNF mRNA nor the translocation of nuclear factor NF-kappa B to the nucleus in macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-kappa B-mediated transcriptional regulation of TNF. |
| T15 |
1373-1463 |
Sentence |
denotes |
However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493. |
| T15 |
1373-1463 |
Sentence |
denotes |
However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493. |
| T16 |
1464-1690 |
Sentence |
denotes |
Further evidence for the translational suppression of TNF is given by experiments using chloram-phenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. |
| T16 |
1464-1690 |
Sentence |
denotes |
Further evidence for the translational suppression of TNF is given by experiments using chloram-phenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. |
| T17 |
1691-1817 |
Sentence |
denotes |
Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493. |
| T17 |
1691-1817 |
Sentence |
denotes |
Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493. |
| T18 |
1818-2004 |
Sentence |
denotes |
Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation. |
| T18 |
1818-2004 |
Sentence |
denotes |
Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation. |